Antiretroviral News and Research

RSS

New nutritional challenges in HIV/AIDS care have emerged

Nutritional therapy for HIV-infected patients is shifting focus. Drug treatments designed to combat the HIV virus have improved, decreasing some nutritional problems, while bringing others to light.

26 Sep 2005

Researchers discover way to dramatically boost the output of immune system cells from the thymus

Mayo Clinic researchers have discovered a way to dramatically boost the output of immune system cells from the thymus, which may lead to improved cancer vaccines, as well as to ways to otherwise strengthen immune responses.

26 Sep 2005

HIV-infected macrophages in the brain continuously travel to part of the brain Alzheimer's disease often damages

Bacteria-eating cells that generally fight infection may cause dementia in HIV patients, University of Florida and University of California at San Francisco researchers have found.

26 Sep 2005

Pocket-size device helps people living with HIV remember their medicine

In a study from Johns Hopkins, a pocket-size device giving electronic-voice reminders to "take your medicine" proves to be a success for people living with HIV whose memory is slightly impaired by the virus.

20 Sep 2005

In some poor countries, free life-saving HIV medicines are being given preferentially to patients

...who have never taken them before (so-called 'treatment-naive patients'), which could have disastrous consequences, says a team of researchers in Uganda.

19 Sep 2005

Potential new way to fight HIV

Researchers have confirmed for the first time the benefit of an innate defense system present in the few patients who remain healthy after years of infection with HIV despite receiving no treatment, according to an article published in the September edition of the Journal of Virology.

1 Sep 2005

Data show that HIV-infected older people not taking HAART have double the risk of death

HIV is often regarded as a disease of young people, due to its status as a drug-related or sexually transmitted disease. However, the number of people over age 50 who are infected with HIV is significant--and growing--according to an article in the Sept. 15 issue of Clinical Infectious Diseases, now available online.

30 Aug 2005

Media reports of drug trials can lack accuracy and reliability

Media reports of drug trials can lack accuracy and reliability, according to a study published in the open access journal BMC International Health and Human Rights.

25 Aug 2005

Scientists say valproic acid can eradicate dormant HIV

Early research by scientists in the U.S. suggests that valproic acid could be a potential way to eradicate dormant HIV infections.

14 Aug 2005

New therapeutic approach that could help eliminate dormant HIV infection

US scientists have tested a new therapeutic approach that could help eliminate dormant HIV infection that current treatments miss. The researchers report these preliminary findings in a proof-of-concept study in this week’s issue of The Lancet.

11 Aug 2005

HAART reduces AIDS rates by 86%

Highly active antiretroviral therapy (HAART) for HIV-infected individuals has reduced the rate of progression to AIDS or death by 86%, according to new research from Bristol University published in The Lancet.

2 Aug 2005

People with HIV in developing countries do just as well on antiretroviral therapy (ART) programs as do people with HIV on ART programs in developed countries

It also shows that people with HIV who are given free ART drugs will do "significantly" better at fighting the disease compared to those who must pay for the drugs.

1 Aug 2005

Combination antiretroviral drug therapy may reduce the risk of mother-to-child HIV transmission

Two new studies support the hypothesis that combination antiretroviral drug therapy may reduce the risk of mother-to-child HIV transmission through breastfeeding, findings that could have significant implications in the developing world.

29 Jul 2005

Ranbaxy receives tentative FDA approval to manufacture and market Zidovudine tablets

India's Ranbaxy Laboratories has announced that it has received tentative approval from the U.S. Food and Drug Administration (USFDA) to manufacture and market Zidovudine Tablets USP, 300 mg.

15 Jul 2005

Police shooting of AIDS protesters by South African police

AIDS Healthcare Foundation (AHF) today expressed its profound outrage over the unprovoked attack -- including what is believed to be the first-ever police shooting of AIDS protesters anywhere worldwide -- by South African police on AIDS activists conducting a peaceful protest.

15 Jul 2005

If global efforts to prevent HIV/AIDS are to work long term, they must avoid suspicions of being unfair

Johns Hopkins infectious disease specialists who have spent more than two decades leading efforts to combat HIV and AIDS worldwide are warning that limited international relief supplies of antiretroviral therapies currently being distributed in Africa, Asia and the Caribbean will not get to those who can least afford to pay for them.

28 Jun 2005

WHO says AIDS fight will only be won with generic drugs

According to the World Health Organisation (WHO) the key to AIDS treatment in the developing world is generic drugs, but the target of 3 million people on therapy by the end of 2005 may now be unattainable.

21 Jun 2005

Inexpensive tests can be used to decide who needs HIV treatment in poor countries

Researchers from the Johns Hopkins Bloomberg School of Public Health, Centers for Disease Control and Prevention and the Chiang Mai University in Thailand, evaluated the ability of inexpensive biological markers, which are obtainable in resource-poor countries, to determine which HIV-infected patients are in the greatest need of antiretroviral therapy.

20 Jun 2005

Dental care needs for HIV patients continue to rise

People with HIV now are living longer and the number of dental patients treated monthly at the Oregon Health & Science University School of Dentistry's Russell Street Clinic continues to grow.

16 Jun 2005

Tentative approval for Lamivudine tablets

The U.S. Food and Drug Administration (FDA) has announced the tentative approval of Lamivudine Tablets manufactured by Aurobindo Pharma LTD. Hyderabad, India.

16 Jun 2005

Antiretroviral News and Research

New nutritional challenges in HIV/AIDS care have emerged

Researchers discover way to dramatically boost the output of immune system cells from the thymus

HIV-infected macrophages in the brain continuously travel to part of the brain Alzheimer's disease often damages

Pocket-size device helps people living with HIV remember their medicine

In some poor countries, free life-saving HIV medicines are being given preferentially to patients

Potential new way to fight HIV

Data show that HIV-infected older people not taking HAART have double the risk of death

Media reports of drug trials can lack accuracy and reliability

Scientists say valproic acid can eradicate dormant HIV

New therapeutic approach that could help eliminate dormant HIV infection

HAART reduces AIDS rates by 86%

People with HIV in developing countries do just as well on antiretroviral therapy (ART) programs as do people with HIV on ART programs in developed countries

Combination antiretroviral drug therapy may reduce the risk of mother-to-child HIV transmission

Ranbaxy receives tentative FDA approval to manufacture and market Zidovudine tablets

Police shooting of AIDS protesters by South African police

If global efforts to prevent HIV/AIDS are to work long term, they must avoid suspicions of being unfair

WHO says AIDS fight will only be won with generic drugs

Inexpensive tests can be used to decide who needs HIV treatment in poor countries

Dental care needs for HIV patients continue to rise

Tentative approval for Lamivudine tablets

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News